Status:
COMPLETED
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Conditions:
Gastric Cancer
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Of those patients who participated in PEGASUS-D FAS clinical trial, patient must sign the informed consent form in order to participate in this extension study. The medical records of the patients wi...
Detailed Description
Of those patients who participated in PEGASUS-D FAS clinical trial, patient must sign the informed consent form in order to participate in this extension study. * Collection of retrospective cohort d...
Eligibility Criteria
Inclusion
- Among the PEGASUS-D Full Analysis Set (FAS) subjects, those who agree to participate in this clinical trial or those who can collect retrospective cohort data after waiving consent according to the consent waiver criteria
Exclusion
- A person who, at the discretion of the investigator, is deemed difficult to participate in this clinical trial.
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 28 2022
Estimated Enrollment :
431 Patients enrolled
Trial Details
Trial ID
NCT05410535
Start Date
September 15 2021
End Date
October 28 2022
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DoJoong Park
Seoul, South Korea